Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Cancer Causes Control. 2023 Jun 17;34(10):829–835. doi: 10.1007/s10552-023-01735-6

Variation in Hysterectomy Prevalence and Trends Among U.S. States and Territories — Behavioral Risk Factor Surveillance System, 2012–2020

Sameer V Gopalani 1,2, Sabitha R Dasari 3, Emily E Adam 1,2, Trevor D Thompson 1, Mary C White 1, Mona Saraiya 1
PMCID: PMC10643045  NIHMSID: NIHMS1938845  PMID: 37329443

Abstract

Purpose:

We estimated up-to-date state- and territory-level hysterectomy prevalence and trends, which can help correct the population at risk denominator and calculate more accurate uterine and cervical cancer rates.

Methods:

We analyzed self-reported data for a population-based sample of 1,267,013 U.S. women aged ≥18 years who participated in the Behavioral Risk Factor Surveillance System surveys from 2012 to 2020. Estimates were age-standardized and stratified by sociodemographic characteristics and geography. Trends were assessed by testing for any differences in hysterectomy prevalence across years.

Results:

Hysterectomy prevalence was highest among women aged 70–79 years (46.7%) and ≥80 years (48.8%). Prevalence was also higher among women who were non-Hispanic (NH) Black (21.3%), NH American Indian and Alaska Native (21.1%), and from the South (21.1%). Hysterectomy prevalence declined by 1.9 percentage points from 18.9% in 2012 to 17.0% in 2020.

Conclusions:

Approximately one in five U.S. women overall and half of U.S. women aged ≥70 years reported undergoing a hysterectomy. Our findings reveal large variations in hysterectomy prevalence within and between each of the four census regions and by race and other sociodemographic characteristics, underscoring the importance of adjusting epidemiologic measures of uterine and cervical cancers for hysterectomy status.

Keywords: Behavioral Risk Factor Surveillance System, cervical cancer, hysterectomy, prevalence, uterine cancer, women's health

INTRODUCTION

Hysterectomy, which includes the removal of the uterus and often the cervix, is one of the most common nonobstetric surgical procedures among U.S. women [1]. Most hysterectomies are for non-cancerous indications, but approximately 10%–17% are undertaken for gynecologic malignancies [2, 3]. Uterine fibroids, abnormal uterine bleeding, and endometriosis are the most common indications for hysterectomy [4]. In recent years, more hysterectomies have been performed in outpatient settings [4-6]; however, this shift to outpatient hysterectomies may have occurred later among Black women [7].

In the U.S., the prevalence of hysterectomy varies by sociodemographic and geographic characteristics. Previous population-based estimates of hysterectomy prevalence are found to be higher among Black women relative to White women [8, 9]. Even after adjusting for the higher prevalence of uterine fibroids among Black women, the Black-White differences in hysterectomy use remained [10]. Higher estimates have also been observed among women living in the South [11, 12]. In addition, higher levels of hysterectomy have been observed among women with lower income and lower education levels [11].

Hysterectomy includes the removal of the uterus and often the cervix. Women without a uterus or cervix are no longer at risk for these cancers, and thus, hysterectomy reduces the population of women at risk for developing uterine and cervical cancer [13]. Measures of cancer incidence often do not adjust for hysterectomy prevalence; however, correcting for hysterectomy prevalence leads to more accurate estimates of uterine [9] and cervical [14] cancer incidence rates. Due to the limited research on population-level hysterectomy trends and the implications for accurate cancer incidence rates, we provide up-to-date hysterectomy prevalence and patterns for U.S. states, the District of Columbia, Puerto Rico, and Guam.

METHODS

Data

Data from the Behavioral Risk Factor Surveillance System (BRFSS) were analyzed for 1,267,013 respondents aged 18 years or older in even-numbered years from 2012 to 2020, representing 127,885,148 women. Based on previous work [15], we examined data from BRFSS because it included the U.S. territories and had a larger sample size (than the National Health Interview Survey) to better support analyses of hysterectomy estimates for smaller subpopulations. BRFSS is a system of annual landline and cellular telephone surveys of the noninstitutionalized U.S. adult population that collects data at the state and local level. The survey uses random digit dialing techniques on both landline telephones and cell phones to conduct the interviews. BRFSS implemented methodological changes in 2011 involving the addition of cell phone interviews and a new weighting method. Consistent with BRFSS guidance, we did not compare pre-2012 data with post-redesign data [16]. The BRFSS question on hysterectomy was part of the measure of cervical cancer screening in the core component and was asked by all jurisdictions in even-numbered years from 2012 to 2020. In 2016, the question on hysterectomy status was not asked in eight states, and these data were suppressed in the public-use data set and not included in our analyses. The median survey response rates were 45.2% (2012), 47.0% (2014), 47.1% (2016), 49.9% (2018), and 47.9% (2020). Information about the survey design, sampling, instrument, and data collection methods are available elsewhere [17].

Measures

The prevalence of respondents who reported a hysterectomy (hysterectomy prevalence) was self-reported and defined as “yes” to the following question: “Have you had a hysterectomy?” Approximately 8.9% (n=113,118) of respondents who answered “don’t know/not sure” or “refused” or were missing for the hysterectomy status question were excluded from the analyses. Respondents who reported being pregnant at the time of survey administration were recoded as not having a hysterectomy.

Hysterectomy prevalence data were examined by age, race/ethnicity, education level, household income, health insurance status, body mass index, and geography. Race and ethnicity were grouped as non-Hispanic White, non-Hispanic Black, non-Hispanic American Indian or Alaska Native, non-Hispanic Asian or Pacific Islander, and Hispanic. A participant’s education level was characterized as either less than high school, high school or GED, some college, or college graduate. Household income was categorized into five groups: <$15,000, $15,000–$24,999, $25,000–$34,999, $35,000–$49,999, and ≥$50,000. Health insurance status was characterized as yes for women who reported having any type of health coverage. Body mass index was expressed per kg/m2 and categorized into the following predefined categories: <18.5, 18.5–24.9, 25.0–29.9, and ≥30.0.

In addition, hysterectomy prevalence was estimated for all U.S. states, the District of Columbia, Puerto Rico, and Guam. Geographic area was also categorized by the four U.S. census regions and nine divisions: Northeast region (New England and Middle Atlantic divisions), Midwest region (East North Central and West North Central divisions), South region (South Atlantic, East South Central, and West South Central divisions), and West region (Mountain and Pacific divisions).

Analysis

Weighted hysterectomy prevalence with 95% confidence intervals (CI) was estimated. All estimates were age-standardized to the 2000 U.S. standard population using the direct method. The absolute change in hysterectomy prevalence between 2012 and 2020 was calculated as the difference in the weighted proportion between the two years and presented with 95% CI. Wald F tests were used to test for any differences in age-standardized estimates of hysterectomy prevalence across years. The increase or decrease in prevalence was considered significant if the P value was less than an alpha of 0.05. Sampling design parameters, such as stratification, clustering, and weighting, were specified using SAS-callable SUDAAN (version 9.4), which accounted for the complex sampling design and nonresponse. Figures were developed using R (version 4.0.3).

Ethics

This study did not require institutional review board approval because it involved analyses of publicly available, fully deidentified data.

RESULTS

From 2012 to 2020, the age-standardized hysterectomy prevalence among adult U.S. women was 17.9% (95% CI: 17.8%, 18.0%) (Table 1). Age-specific hysterectomy prevalence steadily increased with each consecutive age group and was highest among women aged ≥80 years (48.8%). The prevalence of hysterectomy varied by race and ethnicity, with the highest estimates reported among women who were non-Hispanic (NH) Black (21.3%) and NH American Indian and Alaska Native (AI/AN) (21.1%). Estimates were also higher among women with a BMI ≥30 kg/m2 (21.2%) and an annual household income of <$15,000 (20.4%).

Table 1.

Age-specific and age-standardizeda prevalence and patterns of self-reported hysterectomy among adult women aged ≥18 years, by selected characteristics—Behavioral Risk Factor Surveillance System, United States, 2012–2020.

Characteristics No.b Weighted % (95% CI) Absolute percent change
2020 – 2012 (95% CI)c
P value
(any difference
across years)d
 
Overall 333,362 17.9 (17.8, 18.0) −1.9 (−2.3, −1.5) <.0001
 
Survey years
2012 79,607 18.9 (18.6, 19.1)
2014 75,260 18.6 (18.3, 18.8)
2016 63,620 18.0 (17.7, 18.3)
2018 62,020 17.3 (17.0, 17.6)
2020 52,855 17.0 (16.6, 17.3)
 
Age groups (years)
18-29 743 0.6 (0.5, 0.6) −0.2 (−0.4, 0.1) 0.0218
30-39 6,918 4.6 (4.4, 4.8) −1.1 (−1.7, −0.5) 0.0006
40-49 25,701 15.8 (15.4, 16.1) −1.6 (−2.7, −0.4) 0.0009
50-59 63,076 27.5 (27.1, 27.9) −2.2 (−3.6, −0.7) 0.0001
60-69 94,652 36.3 (35.9, 36.7) −6.1 (−7.4, −4.7) <.0001
70-79 88,740 46.7 (46.2, 47.2) −4.8; (−6.5, −3.1) <.0001
≥80 53,532 48.8 (48.1, 49.5) −0.1 (−2.4, 2.3) 0.5300
Missing [no. (%)]e 0 (0%)
 
Race / Ethnicity
Non-Hispanic White 266,811 18.4 (18.3, 18.5) −1.7 (−2.2, −1.3) <.0001
Non-Hispanic Black 31,329 21.3 (20.9, 21.7) −1.5 (−2.9, −0.1) 0.0105
Non-Hispanic AI/AN 4,510 21.1 (20.0, 22.2) −1.9 (−5.5, 1.7) 0.3755
Non-Hispanic Asian 2,279 8.9 (8.0, 9.9) −4.0 (−6.5, −1.5) 0.0003
Non-Hispanic NHPI 605 16.2 (13.5, 19.3) −0.4 (−7.1, 6.3) 0.1095
Hispanic 16,778 15.0 (14.5, 15.4) −1.8 (−3.3, −0.2) 0.0259
Missing [no. (%)]e 4,099 (1.2%)
 
Education level
Less than high school 31,484 19.7 (19.3, 20.2) −3.0 (−4.4, −1.5) <.0001
High school or GED 109,993 20.1 (19.8, 20.4) −1.7 (−2.6, −0.8) <.0001
Some college or technical college 102,283 19.6 (19.3, 19.8) −1.1 (−1.9, −0.3) 0.0043
College graduate 88,903 13.4 (13.3, 13.6) −1.4 (−2.0, −0.9) <.0001
Missing [no. (%)]e 699 (0.2%)
 
Household income
<$15,000 38,651 20.4 (20.0, 20.8) −2.6 (−4.1, −1.1) 0.0001
$15,000–$24,999 60,430 20.1 (19.8, 20.5) −1.7 (−2.8, −0.5) 0.0011
$25,000–$34,999 35,764 19.5 (19.0, 20.0) −1.6 (−3.2, 0.0) 0.0454
$35,000–$49,999 40,692 18.8 (18.4, 19.2) −0.9 (−2.2, 0.4) 0.7555
≥$50,000 95,486 16.0 (15.8, 16.2) −1.4 (−2.0, −0.7) 0.0004
Missing [no. (%)]e 62,339 (18.7%)
 
Health insurance status
Yes 317,820 18.1 (18.0, 18.3) −1.8 (−2.2, −1.4) <.0001
No 14,820 15.4 (14.8, 16.0) −3.3 (−5.1, −1.5) 0.0001
Missing [no. (%)]e 722 (0.2%)
 
Body mass index (kg/m2)
<18.5 5,951 16.2 (15.1, 17.5) −3.0 (−5.8, −0.3) 0.1036
18.5–24.9 96,029 15.2 (15.0, 15.4) −1.5 (−2.2, −0.8) <.0001
25.0–29.9 102,252 18.1 (17.9, 18.4) −2.0 (−2.8, −1.2) <.0001
≥30.0 106,226 21.2 (20.9, 21.4) −2.4 (−3.3, −1.6) <.0001
Missing [no. (%)]e 22,904 (6.9%)

Abbreviations:

AI/AN, American Indian and Alaska Native; CI, confidence interval; GED, General Educational Development; NHPI, Native Hawaiian and Pacific Islander.

Notes:

a.

Age-standardized to the 2000 U.S. standard population using the direct method.

b.

Unweighted number of respondents who reported a hysterectomy.

c.

Absolute percent change = hysterectomy prevalence in 2020 – hysterectomy prevalence in 2012.

d.

P value = testing for any difference across years were calculated using Wald F tests.

e.

Includes don’t know, not sure, and refused.

Hysterectomy prevalence declined from 18.9% in 2012 to 17.0% in 2020 (−1.9; 95% CI: −2.3, −1.5). The decline was largest among women aged 60–69 years (−6.1%; 95% CI: −7.4%, −4.7%).

Overall hysterectomy prevalence varied by U.S. state and territory, and age-standardized estimates ranged from 11.0% (Guam) to 29.2% (Alabama). Hysterectomy prevalence was considerably higher in the South (21.1; 95% CI: 20.9, 21.4) compared to the other three census regions (Appendix Table 1). However, prevalence varied by state within each of the four census regions; in the South region, prevalence ranged from 11.7% in the District of Columbia to 29.2% in Alabama. Estimates declined from 2012 to 2020 for most states and territories (Supplementary File 1), with the largest decline observed in Guam (absolute percent change: −7.0, 95% CI: −10.8, −3.2) and Oregon (absolute percent change: −4.7, 95% CI: −6.7, −2.6) (Figure 1).

Figure 1. Absolute changea in age-standardizedb prevalence of self-reported hysterectomy from 2012 to 2020 among adult women aged ≥18 years, by U.S. state and territory—Behavioral Risk Factor Surveillance System.

Figure 1.

Abbreviations:

CI: confidence interval; DC: District of Columbia

Notes:

a. Absolute percent change = hysterectomy prevalence in 2020 – hysterectomy prevalence in 2012.

b. Age-standardized to the 2000 U.S. standard population using the direct method.

DISCUSSION

Approximately one in five women, and half of the women aged 70 years and older, reported undergoing a hysterectomy in the U.S. Our results show that hysterectomy prevalence remained high in 2020, with modest declines in recent years, consistent with national trends [12, 18]. The main reason for the decline might be the increased availability and adoption of alternative options to hysterectomy, reflecting a shift in clinical practices and patient preferences. Some of these treatment alternatives to hysterectomy are less invasive (including nonsurgical management options) [19], safer [20], and cost-effective [21]. Additional reasons for the declining trend may include improvements in symptom management [22] and increased preference for organ and fertility preservation [23].

Despite a reduction in hysterectomy prevalence, estimates remained higher among Black and AI/AN women. Racial inequities in hysterectomy are often attributed to higher rates of non-cancerous gynecologic conditions [10, 24] and poorer access to quality gynecologic care and alternative treatments [25]. Hysterectomy as a method of forced surgical sterilization disproportionately impacted Black, Native American, and Hispanic women [26, 27]. In addition, many women with lower incomes and who were Black underwent unnecessary hysterectomies as practice for medical students at select teaching hospitals [28]. In a qualitative study, Black women have also reported that alternative management options to hysterectomy were not offered by clinicians [29], which may signal the implicit racial bias among healthcare professionals and its influence on care.

Hysterectomy prevalence among NH Black and NH AI/AN women was highest in the South region, especially in the East South Central and West South Central regions (Supplementary File 2). These findings highlight the importance of understanding racial patterns in hysterectomy by geography, particularly when prevalence can be used to correct uterine and cervical cancer rates. Furthermore, states with a higher prevalence of hysterectomy were mostly concentrated in the South region, especially in the East South Central division, which includes Alabama (29.2%) and Mississippi (27.8%), and West South Central division, which includes Louisiana (27.4%) and Arkansas (27.0%). However, even within the South (and other census regions), there was a wide variation in hysterectomy prevalence among states, indicating within-region variation. The inter-region and within-region variation in hysterectomy prevalence can be considered in future geographic analyses.

The findings in this report are subject to several limitations. Hysterectomy status was self-reported; however, previous studies have found high agreement of self-reported hysterectomy history with clinical confirmation [10] and administrative records [30]. Nonresponse bias could stem from systematic differences between respondents and nonrespondents. To minimize the potential impact of nonresponse, BRFSS implemented raking as a weighting methodology to adjust for nonresponse [16]. The 95% CIs of state-and territory-specific estimates were wide due to limited sample sizes. Finally, estimates by hysterectomy indication (non-cancerous or cancerous) were not ascertained in the survey. Despite these limitations, our analyses benefited from the most recent survey year available and a large, population-based sample that included data from Puerto Rico and Guam.

This study provides a better understanding of hysterectomy prevalence by sociodemographic and geographic characteristics, and our findings can be used to understand the changes in hysterectomy prevalence over time, provide estimates for risk prediction models of gynecologic cancers, and inform future research on corrections of population-based measures. The findings from this study indicate that overall hysterectomy prevalence declined slightly in recent years but remained high among NH Black and NH AI/AN women and women from the South, especially in the East and West South Central divisions. These findings also highlight the importance of understanding variations in hysterectomy prevalence within and between each of the four census regions and adjusting for hysterectomy prevalence whenever uterine and cervical cancer incidence rates and patterns are examined over time and by sociodemographic characteristics.

Supplementary Material

Supplementary file 1

Supplementary File 1.

Figure 1. Age-standardizeda prevalence of self-reported hysterectomy among adult women aged ≥18 years in U.S. states, Puerto Rico, and Guam—Behavioral Risk Factor Surveillance System, 2012 and 2020. Notes: a. Age-standardized to the 2000 U.S. standard population using the direct method

Supplementary file 2

Supplementary File 2.

Table 1. Age-standardized prevalence of self-reported hysterectomy among adult women aged ≥18 years, by US census region, state, and territory -- Behavioral Risk Factor Surveillance System, United States, 2012-2020. Table 2. Age-standardized prevalence of self-reported hysterectomy among adult women aged ≥18 years, by US census divisions and race and ethnicity -- Behavioral Risk Factor Surveillance System, United States, 2012-2020.

Acknowledgement

The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

The authors are grateful for the efforts of the Behavioral Risk Factor Surveillance System state coordinators and survey participants.

Funding

This research was supported in part by a current appointment (SV Gopalani) and past appointment (EE Adam) to the Research Participation Program at the Centers for Disease Control and Prevention (CDC) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and CDC. Sabitha R. Dasari’s work on this project was conducted under a support contract granted to Cyberdata Technologies, Inc. (Contract No. HHSN31620120007W 200-2017-F94805). EE Adam, TD Thompson, MC White, and M Saraiya are current federal employees, and their work on this paper was performed as part of their official duties.

Footnotes

Competing interests

The authors did not report any conflicts of interest.

Data availability

Behavioral Risk Factor Surveillance System data are publicly available.

REFERENCES

  • [1].Fingar KR, Stocks C, Weiss AJ, Steiner CA. Most Frequent Operating Room Procedures Performed in U.S. Hospitals, 2003–2012. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014. [Google Scholar]
  • [2].Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM, et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol. 2008;198:34.e1–7. [DOI] [PubMed] [Google Scholar]
  • [3].Wallace SK, Fazzari MJ, Chen H, Cliby WA, Chalas E. Outcomes and Postoperative Complications After Hysterectomies Performed for Benign Compared With Malignant Indications. Obstet Gynecol. 2016;128:467–75. [DOI] [PubMed] [Google Scholar]
  • [4].Morgan DM, Kamdar NS, Swenson CW, Kobernik EK, Sammarco AG, Nallamothu B. Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women. Am J Obstet Gynecol. 2018;218:425.e1–.e18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Doll KM, Dusetzina SB, Robinson W. Trends in Inpatient and Outpatient Hysterectomy and Oophorectomy Rates Among Commercially Insured Women in the United States, 2000-2014. JAMA Surgery. 2016;151:876–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Wright MA, Doll KM, Myers E, Carpenter WR, Gartner DR, Robinson WR. Changing trends in Black-White racial differences in surgical menopause: a population-based study. Am J Obstet Gynecol. 2021;225:502.e1–.e13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Robinson WR, Cheng MM, Howard AG, Carpenter WR, Brewster WR, Doll KM. For U.S. Black women, shift of hysterectomy to outpatient settings may have lagged behind White women: a claims-based analysis, 2011-2013. BMC Health Serv Res. 2017;17:526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Powell LH, Meyer P, Weiss G, Matthews KA, Santoro N, Randolph JF, et al. Ethnic differences in past hysterectomy for benign conditions. Women's Health Issues. 2005;15:179–86. [DOI] [PubMed] [Google Scholar]
  • [9].Temkin SM, Kohn EC, Penberthy L, Cronin KA, Rubinsak L, Dickie LA, et al. Hysterectomy-corrected rates of endometrial cancer among women younger than age 50 in the United States. Cancer Causes Control. 2018;29:427–33. [DOI] [PubMed] [Google Scholar]
  • [10].Bower JK, Schreiner PJ, Sternfeld B, Lewis CE. Black-White differences in hysterectomy prevalence: the CARDIA study. Am J Public Health. 2009;99:300–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Erekson EA, Weitzen S, Sung VW, Raker CA, Myers DL. Socioeconomic indicators and hysterectomy status in the United States, 2004. J Reprod Med. 2009;54:553–8. [PMC free article] [PubMed] [Google Scholar]
  • [12].Harvey SV, Pfeiffer RM, Landy R, Wentzensen N, Clarke MA. Trends and predictors of hysterectomy prevalence among women in the United States. Am J Obstet Gynecol. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Temkin SM, Minasian L, Noone AM. The End of the Hysterectomy Epidemic and Endometrial Cancer Incidence: What Are the Unintended Consequences of Declining Hysterectomy Rates? Front Oncol. 2016;6:89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Rositch AF, Nowak RG, Gravitt PE. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer. 2014;120:2032–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Adam EE, White MC, Saraiya M. US hysterectomy prevalence by age, race and ethnicity from BRFSS and NHIS: implications for analyses of cervical and uterine cancer rates. Cancer Causes Control. 2022;33:161–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Centers for Disease Control and Prevention. Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal Wkly Rep. 2012;61:410–3. [PubMed] [Google Scholar]
  • [17].Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Data & Documentation. 2021.
  • [18].Wright JD, Huang Y, Li AH, Melamed A, Hershman DL. Nationwide Estimates of Annual Inpatient and Outpatient Hysterectomies Performed in the United States. Obstet Gynecol. 2022;139:446–8. [DOI] [PubMed] [Google Scholar]
  • [19].Laughlin-Tommaso SK. Alternatives to Hysterectomy: Management of Uterine Fibroids. Obstet Gynecol Clin North Am. 2016;43:397–413. [DOI] [PubMed] [Google Scholar]
  • [20].Billow MR, El-Nashar SA. Management of Abnormal Uterine Bleeding with Emphasis on Alternatives to Hysterectomy. Obstet Gynecol Clin North Am. 2016;43:415–30. [DOI] [PubMed] [Google Scholar]
  • [21].Morgan DM, Kamdar NS, Dalton VK, Swenson CW, Moniz MH, Nallamothu B. Savings with expanding use of the levonorgestrel intrauterine device and fewer benign hysterectomies. Am J Obstet Gynecol. 2019;220:116–8.e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. International Journal of Gynecology & Obstetrics. 2020;149:3–9. [DOI] [PubMed] [Google Scholar]
  • [23].Borah BJ, Nicholson WK, Bradley L, Stewart EA. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013;209:319.e1–.e20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Jacoby VL, Fujimoto VY, Giudice LC, Kuppermann M, Washington AE. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol. 2010;202:514–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Sutton MY, Anachebe NF, Lee R, Skanes H. Racial and Ethnic Disparities in Reproductive Health Services and Outcomes, 2020. Obstetrics & Gynecology. 2021;137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Moore AMD. Race, class, caste, disability, sterilisation and hysterectomy. Medical Humanities. 2023;49:27–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Lawrence J. The Indian Health Service and the sterilization of Native American women. Am Indian Q. 2000;24:400–19. [DOI] [PubMed] [Google Scholar]
  • [28].Prather C, Fuller TR, Jeffries WLt, Marshall KJ, Howell AV, Belyue-Umole A, et al. Racism, African American Women, and Their Sexual and Reproductive Health: A Review of Historical and Contemporary Evidence and Implications for Health Equity. Health Equity. 2018;2:249–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].VanNoy BN, Bowleg L, Marfori C, Moawad G, Zota AR. Black Women's Psychosocial Experiences with Seeking Surgical Treatment for Uterine Fibroids: Implications for Clinical Practice. Womens Health Issues. 2021;31:263–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Phipps AI, Buist DS. Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause. 2009;16:576–81. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary file 1

Supplementary File 1.

Figure 1. Age-standardizeda prevalence of self-reported hysterectomy among adult women aged ≥18 years in U.S. states, Puerto Rico, and Guam—Behavioral Risk Factor Surveillance System, 2012 and 2020. Notes: a. Age-standardized to the 2000 U.S. standard population using the direct method

Supplementary file 2

Supplementary File 2.

Table 1. Age-standardized prevalence of self-reported hysterectomy among adult women aged ≥18 years, by US census region, state, and territory -- Behavioral Risk Factor Surveillance System, United States, 2012-2020. Table 2. Age-standardized prevalence of self-reported hysterectomy among adult women aged ≥18 years, by US census divisions and race and ethnicity -- Behavioral Risk Factor Surveillance System, United States, 2012-2020.

Data Availability Statement

Behavioral Risk Factor Surveillance System data are publicly available.

RESOURCES